SCHEMBL3083530

SCHEMBL3083530

CC(C)(C)OC(=O)N1C(=O)[C@@H](O[Si](C)(C)C)[C@H]1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.49
ABCB1 P08183 1/20 0.39
KLK7 P49862 4/20 0.38
RORC P51449 2/20 0.37
GPR119 Q8TDV5 1/20 0.36
KLK5 Q9Y337 3/20 0.36
NR1H2 P55055 3/20 0.36
RXRA P19793 2/20 0.36
NR1H3 Q13133 2/20 0.36
RIPK1 Q13546 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
BCHE P06276 1/20 0.35
GAA P10253 1/20 0.35
THRB P10828 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PRSS1 P07477 1/20 0.35
PRSS2 P07478 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083528 1.00 ELANE (0.49) ELANEABCB1KLK7RORCGPR119
SCHEMBL3082464 1.00 ELANE (0.49) ELANEABCB1KLK7RORCGPR119
SCHEMBL7089023 0.90 ELANE (0.47) ELANEABCB1KLK7RORCGPR119
SCHEMBL7092475 0.90 ELANE (0.47) ELANEABCB1KLK7RORCGPR119
SCHEMBL3070284 0.89 ELANE (0.46) ELANEABCB1KLK7RORCGPR119
SCHEMBL6333635 0.86 ELANE (0.46) ELANEABCB1KLK7RORCGPR119
SCHEMBL5887148 0.86 ELANE (0.46) ELANEABCB1KLK7RORCGPR119
SCHEMBL5745497 0.86 ELANE (0.46) ELANEABCB1KLK7RORCGPR119
SCHEMBL5887150 0.86 ELANE (0.46) ELANEABCB1KLK7RORCGPR119
SCHEMBL7772596 0.86 ELANE (0.46) ELANEABCB1KLK7RORCGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-09-09 US disclosed
US-7667055-B2 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-23 US disclosed
US-7550608-B2 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-23 US disclosed
US-7541458-B2 β-lactam synthesis FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-7358378-B2 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-04-15 US disclosed
EP-1888521-A2 RESOLUTION OF ENANTIOMERIC MIXTURES OF ß-LACTAMS Florida State University Research Foundation, Inc. (US) 2008-02-20 EP disclosed
WO-2006135669-A2 RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-21 WO disclosed
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20060281932-A1 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20060281918-A1 Resolution of enantiomeric mixtures of beta-lactams FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20060281914-A1 Beta-lactam synthesis FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds COASY, PARG, PIN4 ELANE 4817/4885ABCB1 2404/4885KLK7 1470/4885
US-20060281918-A1 Resolution of enantiomeric mixtures of beta-lactams C9, PEPD, PTMA ELANE 794/4885ABCB1 4128/4885KLK7 2592/4885
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS COASY, PARG, PIN4 ELANE 4817/4885ABCB1 2404/4885KLK7 1470/4885
US-20060281914-A1 Beta-lactam synthesis COASY, MANBA, DCXR ELANE 2227/4885ABCB1 2688/4885KLK7 308/4885
US-20060281932-A1 Processes for the preparation of docetaxel PDCD10, PDS5B, DHCR7 ELANE 4061/4885ABCB1 852/4885KLK7 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.